GLP-1 Advisor | One Day MD

Does retatrutide cause muscle loss? The available evidence suggests that retatrutide-associated weight loss includes a reduction in lean mass, as occurs with other effective obesity treatments. However, the available studies do not establish how much actual skeletal muscle an individual will lose, whether the loss affects muscle function, or how much can be prevented through nutrition and exercise. In a published Phase 2 body-composition substudy involving adults with type 2 diabetes, researchers observed substantial fat-mass reductions alongside reductions in lean mass. The results do not show that retatrutide uniquely damages muscle, but they also do not justify assuming that very large weight losses will preserve muscle automatically. The practical priority is to pursue fat loss while preserving strength, physical function, adequate nutrition, and as much useful muscle as possible . Evidence updated October 2026. This article is educational and is not a substitute for ind...

Living tracker · Evidence review: October 17, 2026 · Editorial team: OneDayMD Research Team Retatrutide and CagriSema are two closely watched investigational medicines for obesity and metabolic disease, but they work differently and have been tested in different trials. This living page tracks the most important results, trial status, safety findings and regulatory milestones—while keeping the difference between peer-reviewed evidence and company-reported topline data visible. At a glance: Retatrutide is a single molecule that activates GIP, GLP-1 and glucagon receptors. CagriSema combines semaglutide, a GLP-1 receptor agonist, with cagrilintide, a long-acting amylin analogue. Trial percentages are not directly comparable unless population, dose, duration, comparator and statistical analysis are sufficiently similar. Regulatory and safety note: Retatrutide remains investigational in the official sources reviewed for this update. Novo Nordisk has reported submitting a US...

Updated: October 2026 | Editorial team: OneDayMD | Purpose: Evidence and safety education Peptides are increasingly promoted for faster injury recovery, muscle growth, fat loss, better skin, improved sexual function, sleep and “anti-aging.” Some peptide medicines have transformed modern care. Others are experimental compounds with promising laboratory findings but little reliable evidence in people. The word peptide describes a type of molecule. It is not a guarantee of safety, effectiveness, purity or regulatory approval. Insulin and semaglutide are peptides; so are unapproved compounds sold online as “research chemicals.” Their evidence, manufacturing standards and medical uses are not interchangeable. Key takeaways Approved peptide medicines are not the same as research peptides. Approved medicines have been evaluated for specific uses, doses and risks. BPC-157, TB-500, MOTS-c, KPV, Semax and Epitalon remain investigat...